상세 보기
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
- Park, Jeong-Yeol;
- Kim, Dae-Yeon;
- Kim, Jong-Hyeok;
- Kim, Yong-Man;
- Kim, Young-Tak;
- ... Lee, Jeong-Won;
- 외 6명
WEB OF SCIENCE
34SCOPUS
41초록
Objective: To compare survival outcomes and treatment-related morbidities between radical hysterectomy (RH) and primary chemoradiation therapy (CRT) in patients with bulky early-stage cervical cancer. Methods: We selected 215 patients with stage IB2 and IIA2 cervical cancer (tumor diameter > 4 cm on magnetic resonance imaging) who underwent RH followed by tailored adjuvant therapy (n=147) or primary CRT (n=68) at two tertiary referral centers between 2001 and 2010. Results: About twenty nine percent of patients were cured by RH alone and these patients experienced the best survival outcomes with the lowest morbidity rates. After the median follow-up times of 40 months, 27 RH (18.4%) and 20 CRT (29.4%) patients had recurrence (p=0.068) and 23 (15.6%) and 17 (25%) patients died of disease (p=0.101). The 5-year progression-free survival were 77% and 66% (p=0.047), and the 5-year overall survival were 78% and 67% (p=0.048) after RH and primary CRT, respectively. In multivariate analysis, patients who received primary CRT was at higher risk for tumor recurrence (odds ratio [OR], 2.26; 95% confidence interval [Cl], 1.24 to 4.14; p=0.008) and death (OR, 3.02; 95% Cl, 1.53 to 5.98; p=0.001) than those who received RH. Grade 3-4, early (17% vs. 30.9%, p=0.021) and late (1.4% vs. 8.8%, p=0.007) complications were significantly less frequent after RH than primary CRT. Conclusion: Thirty percent of patients were cured by RH alone. A treatment outcome was better in this retrospective study in terms of morbidity and survival. Randomized trials are needed to confirm this result.
키워드
- 제목
- Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
- 저자
- Park, Jeong-Yeol; Kim, Dae-Yeon; Kim, Jong-Hyeok; Kim, Yong-Man; Kim, Young-Tak; Kim, Young-Seok; Kim, Ha Jeong; Lee, Jeong-Won; Kim, Byoung-Gie; Bae, Duk-Soo; Huh, Seung Jae; Nam, Joo-Hyun
- 발행일
- 2012-10
- 유형
- Article
- 권
- 23
- 호
- 4
- 페이지
- 226 ~ 234
- 언어
- ENG
- 출판사
- 대한부인종양학회
- 발행국가
- 대한민국
- 분량
- 9 페이지
- ISSN
- E 2005-0399
P 2005-0380